COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
13 hedge funds and large institutions have $2.86M invested in COSCIENS Biopharma Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
7% less funds holding
Funds holding: 14 → 13 (-1)
24% less capital invested
Capital invested by funds: $3.76M → $2.86M (-$899K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $20K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$195K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$109K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
+$28.4K |
| 4 |
Morgan Stanley
New York
|
+$19.1K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$13.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$816K |
| 2 |
Renaissance Technologies
New York
|
-$257K |
| 3 |
Jane Street
New York
|
-$65K |
| 4 |
Millennium Management
New York
|
-$63K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$47K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $1.45M | -$257K | -715 | -14% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $867K | -$816K | -2,267 | -46% |
|
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $208K | +$109K | +304 | +90% |
|
|
4
Group One Trading
Chicago,
Illinois
| $177K | +$195K | +543 | New |
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $49K | – | – | – |
|
|
VKH
6
Virtu KCG Holdings
New York
| $46K | +$13.7K | +38 | +37% |
|
|
7
Morgan Stanley
New York
| $26K | +$19.1K | +53 | +183% |
|
|
8
Simplex Trading
Chicago,
Illinois
| $25K | +$28.4K | +79 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $5K | -$10.4K | -29 | -67% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $2K | -$3.24K | -9 | -69% |
|
|
LTFS
11
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
|
12
Jane Street
New York
| – | -$65K | -197 | Closed |
|
|
13
Millennium Management
New York
| – | -$63K | -190 | Closed |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$47K | -143 | Closed |
|
15
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$8.64K | -24 | -96% |
|
CSCI Hedge Fund Activity: Q2 2016 in Review
13 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q2 2016, worth a combined $2.86M — down 24% from $3.76M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CSCI and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 3 added.
The largest buyer was Group One Trading, opening a new position worth an estimated $195K. The largest seller was Sabby Management, cutting an estimated $816K.
- 13 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q2 2016, down from 14 in Q1 2016.
- Funds reported $2.86M of COSCIENS Biopharma Inc. Common Stock stock for Q2 2016, down 24% quarter-over-quarter.
- 2 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q2 2016 and 3 closed out, a net change of -1 holder.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q2 2016 was Group One Trading, an estimated $195K added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q2 2016 was Sabby Management, an estimated $816K sold.
Based on aggregated 13F filings for Q2 2016.